Variant report
Variant | esv1798372 |
---|---|
Chromosome Location | chr6:24158542-24181477 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:34)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:34 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr6:24168141-24168240 | Kidney_OC | kidney: | n/a | n/a |
2 | E2F4 | chr6:24173553-24173742 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | E2F4 | chr6:24167254-24167432 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | EP300 | chr6:24166982-24166991 | K562 | blood: | n/a | n/a |
5 | FOSL2 | chr6:24158419-24158777 | HepG2 | liver: | n/a | n/a |
6 | FOSL2 | chr6:24163688-24165192 | HepG2 | liver: | n/a | n/a |
7 | FOSL2 | chr6:24160707-24161317 | HepG2 | liver: | n/a | chr6:24160780-24160789 chr6:24160779-24160788 chr6:24160780-24160787 chr6:24160780-24160788 |
8 | FOSL2 | chr6:24159209-24160006 | HepG2 | liver: | n/a | n/a |
9 | FOSL2 | chr6:24163094-24163586 | HepG2 | liver: | n/a | n/a |
10 | FOSL2 | chr6:24160061-24160486 | HepG2 | liver: | n/a | n/a |
11 | GATA3 | chr6:24165272-24165392 | SH-SY5Y | brain: | n/a | n/a |
12 | IRF1 | chr6:24170942-24171033 | K562 | blood: | n/a | n/a |
13 | MXI1 | chr6:24178480-24178507 | Hela-S3 | cervix: | n/a | n/a |
14 | POLR2A | chr6:24160353-24160399 | HepG2 | liver: | n/a | n/a |
15 | POLR2A | chr6:24177377-24177431 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr6:24164217-24164302 | HepG2 | liver: | n/a | n/a |
17 | POLR2A | chr6:24169897-24169929 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr6:24160431-24160480 | HepG2 | liver: | n/a | n/a |
19 | POLR2A | chr6:24166320-24166411 | GM12878 | blood: | n/a | n/a |
20 | POLR2A | chr6:24164553-24164697 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr6:24166287-24166314 | HepG2 | liver: | n/a | n/a |
22 | POLR2A | chr6:24166318-24166419 | HepG2 | liver: | n/a | n/a |
23 | POLR2A | chr6:24169825-24169896 | GM12878 | blood: | n/a | n/a |
24 | POLR2A | chr6:24159300-24159340 | HepG2 | liver: | n/a | n/a |
25 | POLR2A | chr6:24160402-24160426 | HepG2 | liver: | n/a | n/a |
26 | POLR2A | chr6:24164317-24164356 | HepG2 | liver: | n/a | n/a |
27 | POLR2A | chr6:24178821-24178983 | GM12878 | blood: | n/a | n/a |
28 | POLR2A | chr6:24164395-24164569 | A549 | lung: | n/a | n/a |
29 | POLR2A | chr6:24166446-24166464 | HepG2 | liver: | n/a | n/a |
30 | POLR2A | chr6:24163866-24164137 | HepG2 | liver: | n/a | n/a |
31 | POLR2A | chr6:24172062-24172083 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr6:24164405-24164678 | HepG2 | liver: | n/a | n/a |
33 | SPI1 | chr6:24176455-24176704 | HL-60 | blood: | n/a | n/a |
34 | STAT3 | chr6:24162902-24163102 | MCF10A-Er-Src | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:24172312-24172362 | NB4 | blood: | n/a |
2 | chr6:24172312-24172362 | HepG2 | liver: | n/a |
3 | chr6:24172312-24172362 | NH-A | brain: | n/a |
4 | chr6:24172312-24172362 | HNPCEpiC | eye: | n/a |
5 | chr6:24172312-24172362 | Caco-2 | colon: | n/a |
6 | chr6:24172312-24172362 | HPAEpiC | pulmonary alveolar: | n/a |
7 | chr6:24172312-24172362 | PrEC | prostate: | n/a |
8 | chr6:24172312-24172362 | U87 | brain: | n/a |
9 | chr6:24172312-24172362 | Hepatocyte | liver: | n/a |
10 | chr6:24172312-24172362 | HRPEpiC | eye: | n/a |
11 | chr6:24172312-24172362 | SK-N-SH | brain: | n/a |
12 | chr6:24172312-24172362 | IMR90 | lung: | fetal |
13 | chr6:24172312-24172362 | BE2_C | brain: | n/a |
14 | chr6:24172312-24172362 | GM12892 | blood: | n/a |
15 | chr6:24172312-24172362 | HL-60 | blood: | n/a |
16 | chr6:24172312-24172362 | GM12878 | blood: | n/a |
17 | chr6:24172312-24172362 | SAEC | small airway: | n/a |
18 | chr6:24172312-24172362 | HEEpiC | esophagus: | n/a |
19 | chr6:24172312-24172362 | CMK | blood: | n/a |
20 | chr6:24172312-24172362 | K562 | blood: | n/a |
21 | chr6:24172312-24172362 | HCM | heart: | n/a |
22 | chr6:24172312-24172362 | ovcar-3 | ovarian: | n/a |
23 | chr6:24172312-24172362 | NT2-D1 | testis: | n/a |
24 | chr6:24172312-24172362 | HEK293 | kidney: | embryo |
25 | chr6:24172312-24172362 | AG04450 | lung: | fetal |
26 | chr6:24172312-24172362 | AG10803 | skin: | n/a |
27 | chr6:24172312-24172362 | HIPEpiC | eye: | n/a |
28 | chr6:24172312-24172362 | RPTEC | kidney: | n/a |
29 | chr6:24172312-24172362 | HMEC | breast: | n/a |
30 | chr6:24172312-24172362 | Jurkat | blood: | n/a |
31 | chr6:24172312-24172362 | BJ | skin: | n/a |
32 | chr6:24172312-24172362 | AoSMC | blood vessel: | n/a |
33 | chr6:24172312-24172362 | T-47D | breast: | n/a |
34 | chr6:24172312-24172362 | HCF | heart: | n/a |
35 | chr6:24172312-24172362 | HCPEpiC | choroid plexus: | n/a |
36 | chr6:24172312-24172362 | LNCaP | prostate: | n/a |
37 | chr6:24172312-24172362 | PFSK-1 | brain: | n/a |
38 | chr6:24172312-24172362 | Hela-S3 | cervix: | n/a |
39 | chr6:24172312-24172362 | GM06990 | blood: | n/a |
40 | chr6:24172312-24172362 | AG04449 | skin: | fetal |
41 | chr6:24172312-24172362 | MCF10A-Er-Src | breast: | n/a |
42 | chr6:24172312-24172362 | A549 | lung: | n/a |
43 | chr6:24172312-24172362 | AG09309 | skin: | n/a |
44 | chr6:24172312-24172362 | HCT-116 | colon: | n/a |
45 | chr6:24172312-24172362 | ProgFib | skin: | n/a |
46 | chr6:24172312-24172362 | GM19239 | blood: | n/a |
47 | chr6:24172312-24172362 | MCF-7 | breast: | n/a |
48 | chr6:24172312-24172362 | PANC-1 | pancreas: | n/a |
49 | chr6:24172312-24172362 | NHDF-neo | bronchial: | n/a |
50 | chr6:24172312-24172362 | HAEpiC | amniotic membrane: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251830 | TF binding region |
ENSG00000251830 | CpG island |
ENSG00000200156 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3857540 | chr6:24158542-24158543 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs368533186 | chr6:24158585-24158586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75492290 | chr6:24158615-24158616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs60661883 | chr6:24158618-24158619 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs189218981 | chr6:24158620-24158621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375265032 | chr6:24158648-24158649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs13199962 | chr6:24158675-24158676 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs569596858 | chr6:24158681-24158682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528902164 | chr6:24158725-24158726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549074369 | chr6:24158726-24158727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191818652 | chr6:24158739-24158740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182859882 | chr6:24158741-24158742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186671864 | chr6:24158743-24158744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571395778 | chr6:24158778-24158779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537342875 | chr6:24158782-24158783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142167118 | chr6:24158817-24158818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191829275 | chr6:24158826-24158827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573929762 | chr6:24158884-24158885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146373616 | chr6:24158897-24158898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569720955 | chr6:24158949-24158950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552986032 | chr6:24158981-24158982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377491019 | chr6:24158984-24158985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572979275 | chr6:24158985-24158986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545144661 | chr6:24159000-24159001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs13203341 | chr6:24159001-24159002 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs78491305 | chr6:24159003-24159004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533701085 | chr6:24159006-24159007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10595921 | chr6:24159028-24159029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531024366 | chr6:24159112-24159113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7754552 | chr6:24159137-24159138 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs572297795 | chr6:24159172-24159173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561447761 | chr6:24159214-24159215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374799821 | chr6:24159280-24159281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs28993070 | chr6:24159301-24159302 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs139606863 | chr6:24159330-24159331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565704161 | chr6:24159430-24159431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528188951 | chr6:24159438-24159439 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534348107 | chr6:24159464-24159465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144341262 | chr6:24159472-24159473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571378928 | chr6:24159492-24159493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536855111 | chr6:24159512-24159513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187073795 | chr6:24159561-24159562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373158617 | chr6:24159565-24159566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536170807 | chr6:24159592-24159593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552947198 | chr6:24159601-24159602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9358752 | chr6:24159636-24159637 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs114262645 | chr6:24159663-24159664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1833033 | chr6:24159670-24159671 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs386406499 | chr6:24159705-24159706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4052668 | chr6:24159721-24159722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:24153800-24200800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr6:24155600-24160400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr6:24156400-24159000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:24157000-24158800 | Enhancers | Brain Germinal Matrix | brain |
5 | chr6:24157600-24158800 | Enhancers | Fetal Lung | lung |
6 | chr6:24157800-24158600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr6:24158000-24158600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr6:24158000-24158600 | Enhancers | Rectal Smooth Muscle | rectum |
9 | chr6:24159000-24159200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:24163600-24177600 | Weak transcription | Fetal Kidney | kidney |
11 | chr6:24164400-24183800 | Weak transcription | Pancreas | Pancrea |
12 | chr6:24170000-24171600 | Weak transcription | HepG2 | liver |
13 | chr6:24171600-24173200 | Strong transcription | HepG2 | liver |
14 | chr6:24171600-24182800 | Weak transcription | Fetal Intestine Small | intestine |
15 | chr6:24172800-24194800 | Weak transcription | Fetal Intestine Large | intestine |
16 | chr6:24173200-24174000 | Weak transcription | HepG2 | liver |
17 | chr6:24174000-24179600 | Strong transcription | HepG2 | liver |
18 | chr6:24177600-24179600 | Strong transcription | Fetal Kidney | kidney |
19 | chr6:24177800-24198400 | Weak transcription | A549 | lung |
20 | chr6:24179600-24181400 | Weak transcription | Fetal Kidney | kidney |
21 | chr6:24179600-24181400 | Weak transcription | HepG2 | liver |
22 | chr6:24181400-24184000 | Strong transcription | Fetal Kidney | kidney |
23 | chr6:24181400-24189600 | Strong transcription | HepG2 | liver |